Transgenic models to assess the pathogenic actions of cytokines in the central nervous system

Molecular Psychiatry

Volumn 2, Issue 2, 1997, Pages 125-129

  Campbell, I L ^a   Stalder, A K ^a   Chiang, C S ^a   Bellinger, R ^a   Heyser, C J ^a   Steffensen, S ^a   Masliah, E ^b   Powell, H C ^b   Gold, L H ^a   Henriksen, S J ^a   Siggins, G R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Astrocyte; Cytokine; GFAP; Neurological disorder; Transgenic mice

Indexed keywords

CYTOKINE; INTERLEUKIN 3; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; COGNITION; DEMYELINATION; ENCEPHALOMYELITIS; IMMUNOPATHOGENESIS; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MENINGOENCEPHALITIS; MICROGLIA; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 8244241104     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000225     Document Type: Article

References (19)

1. Goetzl EJ, Adelman DC, Sreedharan SP. Neuroimmunology. Adv Immunol 1990; 48: 161-190.
2. Plata-Salaman CR. Immunoregulators in the nervous system. Biobehav Rev 1991; 15: 185-215.
3. Merill JE. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 1992; 14: 1-10.
4. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992; 263: C1-C16.
5. Campbell IL. Neuropathogenic actions of cytokines assessed in transgenic mice. Int J Dev Neurosci 1995; 13: 275-284.
6. Campbell IL, Chiang C-S. Cytokine involvement in CNS disease: implications from transgenic mice. Ann NY Acad Sci 1995; 771: 301-312.
7. Campbell IL, Abraham CR, Masliah E et al. Neurologic disease induced in transgenic mice by the cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 1993; 90: 10061-10065.
8. Chiang C-S, Powell HC, Gold L, Samimi A, Campbell IL. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J Clin Invest 1996; 97: 1512-1524.
9. Gold LH, Heyser CJ, Campbell IL. Progressive cognitive impairment in discriminated avoidance in GFAP-IL6 transgenic mice. Soc Neurosci Abs 1995; 21: 2110.
10. Steffensen SC, Campbell IL, Henriksen SJ. Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res 1994; 652: 149-153.
11. Bellinger FP, Madamba SG, Campbell IL, Siggins G. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci Lett 1995; 198: 95-98.
12. Brett FM, Mizisin AP, Powell HC, Campbell IL. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 1995; 54: 766-775.
13. Chiang C-S, Stalder A, Samimi A, Campbell IL. Reactive gliosis as a consequence of interleukin-6 expression in the brain. Studies in transgenic mice. Dev Neurosci 1994; 16: 212-221.
14. Campbell IL. Proliferative angiopathy in the brain induced by the cerebral overexpression of interleukin-6 in transgenic mice. J Cell Biochem 1994; 18A(Supplement): 283.
15. Quagliarello V, Scheid WM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Eng J Med 1992; 327: 864-872.
16. Achim CL, Heyes MP, Wiley CA. Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 1993; 91: 2769-2775.
17. Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991; 87: 949-954.
18. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple-sclerosis brain. J Exp Med 1989; 170: 607-612.
19. Louis J-C, Magal E, Takayama S, Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science (Wash DC) 1993; 259: 689-692.